Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06074276
Other study ID # i23-07_Almond_Collagen
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 4, 2023
Est. completion date December 31, 2024

Study information

Verified date October 2023
Source Integrative Skin Science and Research
Contact Sarah Adnan
Phone 9168074299
Email sarah@integrativeskinresearch.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigate the effects of almond consumption on collagen production, elastin levels, wrinkles, and pigmentation among premenopausal women and postmenopausal women belonging to all Fitzpatrick skin types.


Description:

Almonds are energy-dense and rich in beneficial nutrients including B vitamins, vitamin E, mono- and polyunsaturated fatty acids, protein, fiber, minerals and polyphenols. Polyphenols and vitamin E in almonds provide protection to the body in part, through their ability to combat oxidative stress. Clinical studies have demonstrated beneficial effects of almond consumption on diseases such as diabetes and cardiovascular disease. Almond consumption has been shown to significantly decrease wrinkle severity in two clinical studies conducted with postmenopausal women with Fitzpatrick skin type I and II. Almond intake has also been shown to increase resistance to erythema induced by ultraviolet exposure. The extracellular matrix contains proteins including collagen and elastin, which contributes to the integrity of the skin. Enzymatic and ultraviolet radiation induced degradation and a reduction in synthesis of collagen and elastin contribute to wrinkle formation. Furthermore, the process of menopause decreases the level of estrogen which affects the skin in several ways, including a decrease in skin collagen and hydration, and an increase in wrinkling.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 35 Years to 70 Years
Eligibility Inclusion Criteria: - Subjects 35 to 70 years of age of all skin types - 50% of the subjects will be postmenopausal women determined as >1-year loss of menstrual period - 50% of the subjects will be premenopausal women - BMI 18.5 - 35 kg/m2 - Individuals with a habitual diet that has been maintained for at least 6 months and to be maintained for the duration of the study - Individuals must maintain their usual skincare products, defined as products that has been used for at least 1 month, for the duration of the study Exclusion Criteria: - Those with a nut allergy - Those who are unwilling to discontinue oral collagen supplementation 1 month prior to the start of the study - Individuals who are unwilling to discontinue vitamin E or nut containing supplements 2 weeks prior to and during the intervention. - Individuals who are pregnant or breastfeeding - Change in skincare products during the study - Had a medical or cosmetic procedure such as laser resurfacing or plastic surgery to the face within the last 6 months (include botulinum toxin, dermal fillers, collagen, or other similar cosmetic procedure) - Has an autoimmune photosensitive condition or known genetic condition with a deficiency in collagen production (such as Ehler-Danlos) - Those with a skin disease on their face that would affect the assessment of their skin based on the assessment of the investigator. - Current tobacco smoker or a tobacco smoking history of greater than 10 pack-years

Study Design


Intervention

Other:
Food: whole almonds
60 grams or (~2 oz) will be consumed 5 times per week.
Food: non-nut snack
Protein and calorie matched non-nut-based food will be consumed 5 times per week by mouth

Locations

Country Name City State
United States Integrative Skin Science and Research Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
Integrative Skin Science and Research

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Skin collagen and elastin quantification Assess with biopsy based histological examination 24 weeks
Primary Facial wrinkles Wrinkle severity score measured by Facial Image Analysis System (BTBP 3D image analysis system) 24 weeks
Secondary Pigment intensity score Change in the appearance of facial pigmentation by high resolution photography (BTBP Clarity Pro) and measures intensity of facial pigmentation. Higher scores indicate darker pigmentation. 12 Weeks
Secondary Pigment intensity score Change in the appearance of facial pigmentation by high resolution photography (BTBP Clarity Pro) and measures intensity of facial pigmentation. Higher scores indicate darker pigmentation. 24 Weeks
Secondary Expression of enzymes that either degrade collagen (MMP1) or inhibit collagen degradation (TIMP1) on skin biopsies Assess through biopsy based histological examination 24 Weeks
Secondary Plasma for potential AGE (advanced glycation end products) analysis Blood samples will be collected 12 Weeks
Secondary Plasma for potential AGE (advanced glycation end products) analysis Blood samples will be collected 24 Weeks
Secondary Facial Wrinkles Wrinkle severity score measured by Facial Image Analysis System (BTBP 3D image analysis system) 12 Weeks
See also
  Status Clinical Trial Phase
Completed NCT05098912 - Comparing Polydioxanone Thread Embedding Acupuncture and Manual Acupuncture for Nasolabial Fold Reduction N/A
Completed NCT05271136 - A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum N/A
Completed NCT05096247 - Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device N/A
Completed NCT05097157 - Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions N/A
Completed NCT04128046 - The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation N/A
Active, not recruiting NCT04727099 - Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™ N/A
Active, not recruiting NCT06140628 - A 28-day Clinical Study on Facial Skin Rejuvenation N/A
Not yet recruiting NCT05524779 - BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement N/A
Completed NCT05514782 - A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum N/A
Completed NCT06123572 - A Clinical Study to Assess the Safety and Effectiveness of Anti-Ageing and Skin Brightening Gel N/A
Completed NCT04911374 - An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream N/A
Recruiting NCT04989361 - Soluble Hyaluronic Acid Microneedle VS. Non-ablative Fractional Laser on Infraorbital Wrinkles. N/A
Recruiting NCT04540900 - A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions Phase 1
Recruiting NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology N/A
Completed NCT06366503 - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation N/A
Active, not recruiting NCT06219278 - A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles N/A
Active, not recruiting NCT06192550 - Functional Usability and Feasibility Testing of the Profound Matrix™ System N/A
Completed NCT04650620 - Study to Evaluate the Performance and Safety of the Medical Device Plenhyage® N/A
Completed NCT03729700 - The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome N/A
Completed NCT05102617 - Post Market Usability Evaluation Of The PicoSure Pro Device N/A